Roche bets $4.3 billion on Spark in gene therapy move

Roche Holding AG is to buy U.S.-based Spark Therapeutics in a $4.3 billion deal that will give the Swiss drugmaker a foothold in gene therapy.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news